Bridge Bank Extends $15,000,000 Growth Capital Term Loan to Examity
/PRNewswire/ -- Bridge Bank today announced its Boston-based Technology Banking Group has extended a $15,000,000 growth capital term loan to Examity, a...
Stay updated with breaking news from Life Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bridge Bank today announced its Boston-based Technology Banking Group has extended a $15,000,000 growth capital term loan to Examity, a...
Share: TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Yooma Wellness Inc. (" Yooma") (CSE:YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today announced that it has filed the annual financial statements (the " Financial Statements") for one of its predecessor companies, Yooma Corp., for the financial period from January 1, 2020 to December 31, 2020 (the " Reporting Period"). Yooma was formed by amalgamation on February 10, 2021, when Yooma Corp. completed a reverse takeover of Globalive Technology Inc. (" GTI"). ...
Share this article Share this article NEW YORK, April 22, 2021 /PRNewswire/ -- Cancer research and development are a major part of the biotechnology industry, and there is always room for improvement and growth. Recently, biotech company Perimeter Medical Imaging Al (TSXV: PINK) (OTC: PYNKF) revealed a revolutionary way for surgeons to be able to assess if a cancer has been fully removed, while still in the operating room. Syndax Pharmaceuticals (NASDAQ: SNDX), Nektar Therapeutics (NASDAQ: NKTR), SELLAS Life Sciences Group (NASDAQ: SLS), and Celldex Therapeutics (NASDAQ: CLDX) are also l...
Share this article Share this article CHARLOTTE, N.C., March 11, 2021 /PRNewswire/ -- NN, Inc., (NASDAQ: NNBR), a diversified industrial company, today reported its financial results for the fourth quarter and full year ended December 31, 2020. Fourth-Quarter Results For the fourth quarter, NN posted solid improvements in sales and profitability as the Company's core markets continued to recover from the impact of the COVID-19 pandemic. Key highlights from the quarter include: Net sales increased $8.3 million, or 7.5%, to $119.0 million, compared to $110.7 million for the fourth quarter of...
Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company EMMAC Brings the Largest Vertically Integrated Independent Cannabis Company in Europe with a Presence in Key European Medical Cannabis Markets, Including the United Kingdom, Germany, Italy, Spain, and Portugal With the European Population of Nearly 748 Million 1, the Potential Addressable Market is More than Twice the Size of U.S. Market 10 March, London. EMMAC Life Sciences Group, Europe's large...